News

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern

03/12/2024

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the full year ended December 31, 2023 before the market opens on Wednesday, March 13, 2024.

03/05/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is iSpecimen Inc. (ISPC) a buy, sell, or hold?

iSpecimen Inc. (ISPC) can sell. Click on Rating Page for detail.

What is iSpecimen Inc.'s stock price?

The price of iSpecimen Inc. (ISPC) is 0.2951 and it was updated on 2024-04-24 02:54:09.

Is iSpecimen Inc. (ISPC) overvalued or undervalued?

Currently iSpecimen Inc. (ISPC) is in undervalued.

News

From:

To:

News
iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript iSpecimen Inc. (NASDAQ:ISPC ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Carly Lejnieks - Vice President of Marketing. Conference Call Participants Matt Hewitt - Craig Hallum Operator Good day, everyone, and welcome to iSpecimens Third Quarter 2020 Results Conference Call. Fri, Nov. 03, 2023
iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript iSpecimen Inc. (NASDAQ:ISPC ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Eric Langlois - Chief Revenue Officer Evan Cox - Vice President of Product Management Conference Call Participants Operator Good day, everyone, and welcome to iSpecimen's Second Quarter 2023 Results Conference Call. At this time participants are in a listen-only mode. Sat, Aug. 05, 2023
iSpecimen to Report Second Quarter 2023 Results on August 2, 2023 LEXINGTON, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the second quarter ended June 30, 2023 before the market opens on Wednesday, August 2, 2023. Tue, Jul. 25, 2023
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023 LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group LLC (“Maxim”) and M-Vest, a division of Maxim, on Thursday, June 1, 2023. Tue, May. 23, 2023
iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript iSpecimen Inc. (NASDAQ:ISPC ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Tracy Curley - Chief Executive Officer Benjamin Beilak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig Hallum Capital Group Operator Good morning, and welcome to iSpecimen First Quarter 2023 Earnings Conference Call [Operator Instructions]. Please note that this event is being recorded. Sat, May. 06, 2023

Transcripts

Transcipts Data
iSpecimen Inc. (ISPC) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Fri, Nov. 03, 2023
iSpecimen Inc. (ISPC) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Sat, Aug. 05, 2023
iSpecimen Inc. (ISPC) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Sat, May. 06, 2023
iSpecimen Inc. (ISPC) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Tue, Mar. 14, 2023
iSpecimen Inc. (ISPC) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Tue, Nov. 08, 2022
iSpecimen Inc. (ISPC) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Mon, Aug. 08, 2022
iSpecimen Inc. (ISPC) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Sat, May. 14, 2022

SEC Filings

SEC Filings
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 04/11/2024
iSpecimen Inc. (ISPC) - PRE 14A SEC Filings 03/28/2024
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 03/26/2024
iSpecimen Inc. (ISPC) - 3 SEC Filings 03/26/2024
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 03/14/2024
iSpecimen Inc. (ISPC) - 10-K - Current report SEC Filings 03/13/2024
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 03/05/2024
iSpecimen Inc. (ISPC) - 424B5 SEC Filings 03/05/2024
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 02/15/2024
iSpecimen Inc. (ISPC) - SC 13G/A SEC Filings 02/13/2024
iSpecimen Inc. (ISPC) - 5 SEC Filings 02/08/2024
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 12/21/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 11/02/2023
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 11/02/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 10/23/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 10/10/2023
iSpecimen Inc. (ISPC) - 4 SEC Filings 09/15/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 09/06/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 08/02/2023
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 08/02/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 07/07/2023
iSpecimen Inc. (ISPC) - 4 SEC Filings 06/01/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 05/25/2023
iSpecimen Inc. (ISPC) - 4 SEC Filings 05/17/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 05/04/2023
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 05/04/2023
iSpecimen Inc. (ISPC) - SC 13D SEC Filings 04/17/2023
iSpecimen Inc. (ISPC) - DEFA14A SEC Filings 04/10/2023
iSpecimen Inc. (ISPC) - DEF 14A SEC Filings 04/10/2023
iSpecimen Inc. (ISPC) - ARS SEC Filings 04/10/2023
iSpecimen Inc. (ISPC) - PRE 14A SEC Filings 03/31/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 03/31/2023
iSpecimen Inc. (ISPC) - 10-K/A - Current report SEC Filings 03/30/2023
iSpecimen Inc. (ISPC) - 10-K - Current report SEC Filings 03/21/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 03/14/2023
iSpecimen Inc. (ISPC) - SC 13G/A SEC Filings 02/13/2023
iSpecimen Inc. (ISPC) - 5 SEC Filings 02/10/2023
iSpecimen Inc. (ISPC) - 4 SEC Filings 01/19/2023
iSpecimen Inc. (ISPC) - 4 SEC Filings 01/13/2023
iSpecimen Inc. (ISPC) - SC 13G/A SEC Filings 01/12/2023
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 01/10/2023
iSpecimen Inc. (ISPC) - 424B3 SEC Filings 12/30/2022
iSpecimen Inc. (ISPC) - SC 13G/A SEC Filings 12/27/2022
iSpecimen Inc. (ISPC) - 3 SEC Filings 12/01/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 11/28/2022
iSpecimen Inc. (ISPC) - 4 SEC Filings 11/14/2022
iSpecimen Inc. (ISPC) - 4 SEC Filings 11/10/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 11/08/2022
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 11/08/2022
iSpecimen Inc. (ISPC) - 4 SEC Filings 11/04/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 10/28/2022
iSpecimen Inc. (ISPC) - SC 13G SEC Filings 09/28/2022
iSpecimen Inc. (ISPC) - SC 13G SEC Filings 09/27/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 09/22/2022
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 08/08/2022
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 08/08/2022
iSpecimen Inc. (ISPC) - 424B3 SEC Filings 08/05/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 08/04/2022
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 08/04/2022
iSpecimen Inc. (ISPC) - UPLOAD SEC Filings 08/03/2022
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 08/03/2022
iSpecimen Inc. (ISPC) - S-3 SEC Filings 07/29/2022
iSpecimen Inc. (ISPC) - S-3 SEC Filings 07/28/2022
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 07/13/2022
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 07/13/2022
iSpecimen Inc. (ISPC) - UPLOAD SEC Filings 07/08/2022
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 07/08/2022
iSpecimen Inc. (ISPC) - S-3 SEC Filings 07/01/2022
iSpecimen Inc. (ISPC) - 4 SEC Filings 06/24/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 06/21/2022
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 06/07/2022
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 06/07/2022
iSpecimen Inc. (ISPC) - 424B3 SEC Filings 06/07/2022
iSpecimen Inc. (ISPC) - POS AM SEC Filings 05/26/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 05/26/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 05/10/2022
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 05/10/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 04/29/2022
iSpecimen Inc. (ISPC) - DEFA14A SEC Filings 04/14/2022
iSpecimen Inc. (ISPC) - DEF 14A SEC Filings 04/14/2022
iSpecimen Inc. (ISPC) - PRE 14A SEC Filings 03/30/2022
iSpecimen Inc. (ISPC) - 10-K - Current report SEC Filings 03/22/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 03/07/2022
iSpecimen Inc. (ISPC) - 4 SEC Filings 02/24/2022
iSpecimen Inc. (ISPC) - 4 SEC Filings 02/23/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 02/17/2022
iSpecimen Inc. (ISPC) - SC 13G/A SEC Filings 02/14/2022
iSpecimen Inc. (ISPC) - SC 13G SEC Filings 02/14/2022
iSpecimen Inc. (ISPC) - 5 SEC Filings 02/14/2022
iSpecimen Inc. (ISPC) - SC 13G SEC Filings 02/07/2022
iSpecimen Inc. (ISPC) - SC 13G SEC Filings 01/24/2022
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 01/10/2022
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 12/27/2021
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 12/27/2021
iSpecimen Inc. (ISPC) - 424B3 SEC Filings 12/23/2021
iSpecimen Inc. (ISPC) - UPLOAD SEC Filings 12/21/2021
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 12/21/2021
iSpecimen Inc. (ISPC) - S-8 SEC Filings 12/16/2021
iSpecimen Inc. (ISPC) - S-1 SEC Filings 12/14/2021
iSpecimen Inc. (ISPC) - D SEC Filings 12/09/2021
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 12/02/2021
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 11/29/2021
iSpecimen Inc. (ISPC) - 4 SEC Filings 11/29/2021
iSpecimen Inc. (ISPC) - 4 SEC Filings 11/17/2021
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 11/04/2021
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 11/04/2021
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 08/16/2021
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 08/10/2021
iSpecimen Inc. (ISPC) - 10-Q - Quarterly Report SEC Filings 08/10/2021
iSpecimen Inc. (ISPC) - SC 13G SEC Filings 07/09/2021
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 07/01/2021
iSpecimen Inc. (ISPC) - 4 SEC Filings 06/23/2021
iSpecimen Inc. (ISPC) - 8-K - Current report SEC Filings 06/22/2021
iSpecimen Inc. (ISPC) - 424B4 SEC Filings 06/21/2021
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 06/17/2021
iSpecimen Inc. (ISPC) - 3 SEC Filings 06/17/2021
iSpecimen Inc. (ISPC) - EFFECT SEC Filings 06/16/2021
iSpecimen Inc. (ISPC) - CERT SEC Filings 06/16/2021
iSpecimen Inc. (ISPC) - 3 SEC Filings 06/16/2021
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 06/14/2021
iSpecimen Inc. (ISPC) - 8-A12B SEC Filings 06/14/2021
iSpecimen Inc. (ISPC) - FWP SEC Filings 05/28/2021
iSpecimen Inc. (ISPC) - S-1/A SEC Filings 05/27/2021
iSpecimen Inc. (ISPC) - S-1/A SEC Filings 05/13/2021
iSpecimen Inc. (ISPC) - S-1/A SEC Filings 04/27/2021
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 04/27/2021
iSpecimen Inc. (ISPC) - UPLOAD SEC Filings 04/26/2021
iSpecimen Inc. (ISPC) - S-1/A SEC Filings 04/02/2021
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 04/02/2021
iSpecimen Inc. (ISPC) - UPLOAD SEC Filings 02/01/2021
iSpecimen Inc. (ISPC) - S-1/A SEC Filings 01/20/2021
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 01/20/2021
iSpecimen Inc. (ISPC) - UPLOAD SEC Filings 01/15/2021
iSpecimen Inc. (ISPC) - S-1/A SEC Filings 12/31/2020
iSpecimen Inc. (ISPC) - CORRESP SEC Filings 12/31/2020
iSpecimen Inc. (ISPC) - UPLOAD SEC Filings 12/14/2020
iSpecimen Inc. (ISPC) - S-1 SEC Filings 11/19/2020
iSpecimen Inc. (ISPC) - D SEC Filings 08/16/2018
iSpecimen Inc. (ISPC) - D SEC Filings 03/29/2017
iSpecimen Inc. (ISPC) - D SEC Filings 09/05/2014
iSpecimen Inc. (ISPC) - D SEC Filings 09/25/2012

Press Releases

StockPrice Release
Ispecimen reports full year 2023 results 03/14/2024
Ispecimen reschedules full year 2023 earnings release and conference call 03/12/2024
Ispecimen to report full year 2023 financial results on march 13, 2024 03/05/2024
Ispecimen and trimetis life sciences announce strategic partnership to help transform tissue-based research 01/23/2024
Ispecimen to participate in maxim group healthcare it virtual conference, january 24 & 25, 2024 01/18/2024
Ispecimen strengthens global oncology biospecimen offering 12/07/2023
Ispecimen reports third quarter 2023 financial and operating results 11/02/2023
Ispecimen expands proprietary provider network to help advance infectious disease research 10/26/2023
Ispecimen preannounces third quarter 2023 revenue increase of 60-70% sequentially 10/23/2023
Ispecimen launches next-day quote service for medical researchers and biospecimen providers 09/28/2023
Ispecimen expands provider network to enhance support for women's health research 09/13/2023
Ispecimen announces organizational changes to enhance operational efficiencies and drive profitability 09/06/2023
Ispecimen launches new virtual cancer sequencing procurement program 08/30/2023
Ispecimen enhances proprietary marketplace platform to streamline biospecimen matchmaking for researchers and providers 08/16/2023
Ispecimen introduces new marketplace functionality to streamline access to clinical remnant samples for researchers 08/09/2023
Ispecimen reports second quarter 2023 financial and operating results 08/02/2023
Ispecimen to report second quarter 2023 results on august 2, 2023 07/25/2023
Thirteen new biospecimen suppliers added to ispecimen's proprietary provider network 07/06/2023
Ispecimen to participate in maxim's healthcare it virtual conference on june 1, 2023 05/23/2023
Ispecimen to participate in the aegis virtual conference on may 4, 2023 04/24/2023
Ispecimen reports full year 2022 results 03/14/2023
Ispecimen to report fourth quarter and full year 2022 results on march 14, 2023 02/28/2023
Ispecimen expands biospecimen provider network 02/08/2023
Ispecimen appoints eric langlois as chief revenue officer 01/24/2023
Ispecimen to participate in the sequire biotechnology conference on february 2, 2023 01/23/2023
Ispecimen to participate in maxim's healthcare it virtual conference on january 25, 2023 01/19/2023
Ispecimen names tracy curley as chief executive officer 01/10/2023
Ispecimen appoints joseph j. basile to board of directors 12/05/2022
Ispecimen reports third quarter 2022 financial and operating results 11/08/2022
Ispecimen launches new open feasibilities dashboard on the ispecimen marketplace platform to enhance biospecimen fulfillment for global partner network 10/27/2022
Ispecimen to report third quarter 2022 results on november 8, 2022 10/25/2022
Ispecimen to participate in the thinkequity conference on october 26, 2022 10/18/2022
Ispecimen launches marketplace onsite program to optimize biospecimen procurement process for sample providers 10/04/2022
Ispecimen names chief financial officer, tracy curley, interim ceo 09/22/2022
Ispecimen to participate in the h.c. wainwright 24th annual global investment conference on september 12-14, 2022 08/31/2022
Ispecimen reports second quarter 2022 financial and operating results 08/04/2022
Ispecimen to report second quarter 2022 results on august 4, 2022 07/21/2022
Ispecimen adds new global biospecimen suppliers to proprietary marketplace platform for researchers to leverage 07/07/2022
Ispecimen appoints evan cox as vice president of product management 06/08/2022
Ispecimen presents new research to optimize biobanking at international society for biological and environmental repositories 2022 annual meeting 05/19/2022
Ispecimen reports first quarter 2022 financial and operating results 05/10/2022
Ispecimen unveils enhanced ispecimen marketplace platform to help scientists more efficiently find desired biospecimens for research 04/26/2022
Ispecimen adds acutis diagnostics to marketplace platform to support oncology and infectious disease research 04/13/2022
Ispecimen to participate in maxim's 2022 virtual growth conference on march 28-30, 2022 03/15/2022
Ispecimen's global biospecimen marketplace surpasses 200 suppliers 03/08/2022
Ispecimen to participate in the aegis virtual conference on february 24, 2022 02/10/2022
Ispecimen to report fourth quarter and full year 2021 results on february 17, 2022 02/03/2022
Ispecimen inc. announces closing of approximately $21 million private placement 12/01/2021
Ispecimen inc. announces $21 million private placement 11/29/2021
Ispecimen selected by u.s. government and private researchers to supply critical human biospecimens for advanced phase of covid-19 research 11/22/2021
Ispecimen expands global biospecimen supplier network and access to human biospecimens needed to help accelerate development of liquid biopsies 10/07/2021
Ispecimen to participate in the h.c. wainwright 23rd annual global investment conference on september 13-15, 2021 09/01/2021
Ispecimen expands human biospecimen offerings for cancer researchers 08/18/2021
Ispecimen inc. interview to air on the redchip money report® on bloomberg tv 08/12/2021
Ispecimen reports second quarter 2021 financial results 08/10/2021
Ispecimen launches enhanced custom collection service 07/29/2021
Ispecimen to report second quarter 2021 results on august 10, 2021 07/27/2021
Ispecimen announces closing of over-allotment option in connection with its initial public offering 07/01/2021
Ispecimen announces closing of initial public offering 06/21/2021

More Headlines

News
iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023 LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Aegis Conference to be held virtually on May 2-4, 2023. 04/24/2023
iSpecimen Inc. (ISPC) Q4 2022 Earnings Call Transcript iSpecimen Inc. (NASDAQ:ISPC ) Q4 2022 Earnings Call Transcript March 14, 2023 8:30 AM ET Company Participants Allison Soss - Investor Relations-KCSA Strategic Communications Tracy Curley - Chief Executive Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Allen Klee - Maxim Group Operator Good day, everyone and welcome to iSpecimen's Full Year 2022 Conference Call. At this time, participants will be in a listen-only mode. 03/14/2023
iSpecimen sees 4Q revenue rise by 28% as it focuses on its supplier network and fulfillment efficiency iSpecimen Inc said its revenue jumped 28% year-over-year in the fourth quarter as it made quick improvements to supplier utilization rates to boost overall fulfillment efficiency. For the period ended December 31, 2022, the Lexington, Massachusetts-based company reported revenue of $3.2 million, compared to $2.5 million in 4Q 2021. 03/14/2023
iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023 LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022, before the markets open on Tuesday, March 14, 2023. 02/28/2023
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on January 25, 2023 LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group and M-Vest on Wednesday, January 25, 2023. 01/19/2023
iSpecimen Inc. (ISPC) Q3 2022 Earnings Call Transcript iSpecimen Inc. (NASDAQ:ISPC ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Allison Soss - IR Tracy Curley - Interim-CEO and CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Operator Good day, everyone, and welcome to the iSpecimen Third Quarter 2022 Conference Call. [Operator Instructions] This conference call is being recorded. 11/08/2022
iSpecimen to Report Third Quarter 2022 Results on November 8, 2022 LEXINGTON, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the third quarter ended September 30, 2022, before the markets open on Tuesday, November 8, 2022. 10/25/2022
iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 LEXINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022. 08/31/2022
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q2 2022 Results - Earnings Call Transcript iSpecimen Inc. (NASDAQ:ISPC ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Allison Soss - Senior Vice President of Investor Relations Christopher Ianelli - President & Chief Executive Officer Jill Mullan - Chief Operating Officer Tracy Curley - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton James Lieberman - Revere Securities Operator Good day, everyone and welcome to iSpecimen Second Quarter 2022 Conference Call. [Operator Instructions] A replay of today's call will be available on the Investor Relations section of iSpecimen's website and will remain posted there for the next 30 days. 08/08/2022
iSpecimen to Report Second Quarter 2022 Results on August 4, 2022 LEXINGTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the second quarter ended June 30, 2022, before the markets open on Thursday, August 4, 2022. 07/21/2022
Why iSpecimen Shares Are Gaining Today? iSpecimen Inc (NASDAQ: ISPC) has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research. The new suppliers include a cancer-focused biobank in the U.S., which contains a differentiated range of pre-. 07/07/2022
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q1 2022 Results - Earnings Call Transcript iSpecimen Inc. (NASDAQ:ISPC ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Allison Soss - Investor Relations Christopher Ianelli - Chief Executive Officer and President Tracy Curley - Chief Financial Officer Jill Mullan - Chief Operating Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton Operator Good day, everyone, and welcome to iSpecimen's First Quarter 2022 Conference Call. [Operator Instructions] This conference is being recorded. 05/14/2022
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q4 2021 Results - Earnings Call Transcript iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q4 2021 Results - Earnings Call Transcript 02/17/2022
iSpecimen to Participate in the Aegis Virtual Conference on February 24, 2022 LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President, will participate in the Aegis Capital Corp. Virtual Conference to be held virtually on February 23-25, 2022. 02/10/2022
iSpecimen to Report Fourth Quarter and Full Year 2021 Results on February 17, 2022 LEXINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2021, before the markets open on Thursday, February 17, 2022. 02/03/2022
iSpecimen Stock (ISPC): Why The Price Went Up Today The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 4% during intraday trading today. This is why it happened. 01/13/2022
Why ISpecimen Shares Are Surging Higher Today ISpecimen Inc (NASDAQ: ISPC) is trading higher Thursday after the company announced the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research. ISpecimen said the reference lab has the capacity to sequence hundreds of COVID-19 positive swabs per week. 01/13/2022
ISPC Stock: What Is Going on With Little-Known iSpecimen Today? ISPC stock received a $20 price target from Craig-Hallum today. This comes after iSpecimen made several developments during 2021. 01/04/2022
See why Craig-Hallum Is Bullish On iSpecimen Craig-Hallum initiated coverage of iSpecimen Inc (NASDAQ:ISPC) with a Buy rating and $20 price target. "Much the way Amazon has become the go-to platform for buyers and sellers of consumer goods," the analyst believes iSpecimen can become the go-to platform for human biospecimens, writes analyst Matthew Hewitt. 01/04/2022
5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge movie. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile examples of short squeezes earlier this year. 12/20/2021
iSpecimen (ISPC) Stock: Why The Price Increased Today The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 7% pre-market today. This is why it happened. 11/30/2021
iSpecimen (ISPC) Stock: Why The Price Fell Today The stock price of iSpecimen Inc (NASDAQ: ISPC) fell by over 6% pre-market today. This is why it happened. 11/29/2021
iSpecimen (ISPC) Stock: Why The Price Surged Today The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 65% pre-market today. This is why it happened. 11/26/2021
Here is why iSpecimen is up 50% today iSpecimen Inc (NASDAQ: ISPC) is a human biospecimens marketplace that operates online. It announced that private companies and the U.S government had contracted it to be a part of the new advanced Covid-19 research efforts providing the process with human biospecimens. 11/23/2021
Why ISpecimen Shares Continue To Move Higher Today ISpecimen Inc (NASDAQ: ISPC) is trading higher Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes and testing validity among multiple population segments. ISpecimen's work on COVID-19 began immediately after the outbreak last year when it began helping researchers monitor antibody development for possible guidance on immunity. 11/23/2021
iSpecimen (ISPC) Stock: Why The Price Surged Today The stock price of iSpecimen Inc. (NASDAQ: ISPC) increased by over 85% pre-market today. This is why it happened. 11/23/2021
3 Hot Penny Stocks to Watch That Exploded Today, One Up 93% Why these three penny stocks exploded today The post 3 Hot Penny Stocks to Watch That Exploded Today, One Up 93% appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 11/22/2021
PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today PainReform (PRFX) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company. The post PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today appeared first on InvestorPlace. 11/22/2021
ISPC Stock: The Covid-19 Research News That Has iSpecimen Shares Skyrocketing 100% Today iSpecimen (ISPC) stock is up Monday after announcing partnerships with the U.S. Government and private researchers for Covid-19 research. The post ISPC Stock: The Covid-19 Research News That Has iSpecimen Shares Skyrocketing 100% Today appeared first on InvestorPlace. 11/22/2021
iSpecimen Stock Rallies On Supply Pact Of Human Biospecimens For COVID-19 Research iSpecimen Inc (NASDAQ: ISPC), an online marketplace for human biospecimens, has been contracted to support new advanced research on COVID-19. In the last ten months, the Company has partnered with multiple research and health care organizations on diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products. 11/22/2021
iSpecimen (ISPC) Stock: Why The Price Surged Today The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 135% pre-market today. This is why it happened. 11/22/2021
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q3 2021 Results - Earnings Call Transcript iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q3 2021 Results - Earnings Call Transcript 11/06/2021
iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021 LEXINGTON, Mass., Sept. 1, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. 09/01/2021
iSpecimen Expands Human Biospecimen Offerings for Cancer Researchers LEXINGTON, Mass., Aug. 18, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced it has grown its cancer-related supplier network despite lockdowns, slowdowns, and sustained concern around the COVID-19 pandemic. 08/18/2021
iSpecimen Inc. Interview to Air on the RedChip Money Report® on Bloomberg TV LEXINGTON, Mass., Aug. 12, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that an interview with its CEO and President, Dr. Christopher Ianelli, will air on The RedChip Money Report® on Bloomberg TV, at 7 p.m. 08/12/2021
iSpecimen Reports Second Quarter 2021 Financial Results LEXINGTON, Mass., Aug. 10, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today reported its financial results for the three-month period ended June 30, 2021. 08/10/2021
iSpecimen Launches Enhanced Custom Collection Service LEXINGTON, Mass., July 29, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that it has enhanced its custom biofluids collection service to offer life sciences organizations faster delivery of urgently needed research samples. 07/29/2021
iSpecimen to Report Second Quarter 2021 Results on August 10, 2021 LEXINGTON, Mass., July 27, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its financial results for the second quarter ended June 30, 2021, before the market open on Tuesday, August 10, 2021. 07/27/2021
iSpecimen: High Growth Marketplace At A Discount iSpecimen: High Growth Marketplace At A Discount 07/07/2021
iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering LEXINGTON, Mass., July 1, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of the issuance of an additional 337,500 shares of its common stock pursuant to the full exercise of the underwriters' over-allotment option in connection with the Company's initial public offering (the "IPO"). 07/01/2021
iSpecimen Announces Closing of Initial Public Offering LEXINGTON, Mass., June 21, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of its previously announced initial public offering of 2,250,000 shares of its common stock at a price of $8.00 per share, for gross proceeds of $18,000,000 before deducting underwriting discounts, commissions and offering expenses. 06/21/2021
3 Biotechs Plus a Mortgage Lender Go Public Today The companies are Verve Therapeutics, Lyell Immunopharma, iSpecimen and Angel Oak Mortgage. 06/17/2021

Unlock

ISPC Ratings Summary

ISPC Quant Ranking